Clinical trial
Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest…
NCT00006433 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00006433 |
|---|---|
| Title | Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast Cancer |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Doxil, heat treatment |
| Start date | Jan 1, 2000 |
| First posted | Nov 6, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: